Compare YCBD & SONM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | YCBD | SONM |
|---|---|---|
| Founded | 2015 | 1999 |
| Country | United States | United States |
| Employees | 42 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1M | 6.2M |
| IPO Year | N/A | 2019 |
| Metric | YCBD | SONM |
|---|---|---|
| Price | $0.73 | $3.79 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | ★ 120.6K | 21.3K |
| Earning Date | 05-15-2026 | 04-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 5.01 |
| Revenue | N/A | ★ $58,298,000.00 |
| Revenue This Year | $12.70 | N/A |
| Revenue Next Year | $7.00 | N/A |
| P/E Ratio | ★ N/A | $0.84 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.48 | $0.52 |
| 52 Week High | $2.56 | $12.30 |
| Indicator | YCBD | SONM |
|---|---|---|
| Relative Strength Index (RSI) | 52.28 | 41.87 |
| Support Level | $0.70 | $2.66 |
| Resistance Level | $0.74 | $5.83 |
| Average True Range (ATR) | 0.04 | 0.63 |
| MACD | 0.01 | -0.12 |
| Stochastic Oscillator | 83.33 | 28.38 |
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
DNA X Inc is engaged in providing crypto trading services through its online platform, enabling users to buy, sell, and exchange cryptocurrencies, as well as execute automated trading strategies between currency pairs. The company generates revenue from commissions and fees on trading activity.